Cargando…

Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care

INTRODUCTION: Early administration of antibiotics for sepsis, and of fluid boluses and vasoactive agents for septic shock, is recommended. Evidence for this in children is limited. METHODS: The Alberta Sepsis Network prospectively enrolled eligible children admitted to the Pediatric Intensive Care U...

Descripción completa

Detalles Bibliográficos
Autores principales: van Paridon, Bregje M., Sheppard, Cathy, G, Garcia Guerra, Joffe, Ari R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539944/
https://www.ncbi.nlm.nih.gov/pubmed/26283545
http://dx.doi.org/10.1186/s13054-015-1010-x
_version_ 1782386171715780608
author van Paridon, Bregje M.
Sheppard, Cathy
G, Garcia Guerra
Joffe, Ari R.
author_facet van Paridon, Bregje M.
Sheppard, Cathy
G, Garcia Guerra
Joffe, Ari R.
author_sort van Paridon, Bregje M.
collection PubMed
description INTRODUCTION: Early administration of antibiotics for sepsis, and of fluid boluses and vasoactive agents for septic shock, is recommended. Evidence for this in children is limited. METHODS: The Alberta Sepsis Network prospectively enrolled eligible children admitted to the Pediatric Intensive Care Unit (PICU) with sepsis from 04/2012-10/2014. Demographics, severity of illness, and outcomes variables were prospectively entered into the ASN database after deferred consent. Timing of interventions were determined by retrospective chart review using a study manual and case-report-form. We aimed to determine the association of intervention timing and outcome in children with sepsis. Univariate (t-test and Fisher’s Exact) and multiple linear regression statistics evaluated predictors of outcomes of PICU length of stay (LOS) and ventilation days. RESULTS: Seventy-nine children, age median 60 (IQR 22–133) months, 40 (51 %) female, 39 (49 %) with severe underlying co-morbidity, 44 (56 %) with septic shock, and median PRISM-III 10.5 [IQR 6.0-17.0] were enrolled. Most patients presented in an ED: 36 (46 %) at an outlying hospital ED, and 21 (27 %) at the Children’s Hospital ED. Most infections were pneumonia with/without empyema (42, 53 %), meningitis (11, 14 %), or bacteremia (10, 13 %). The time from presentation to acceptable antibiotic administration was a median of 115.0 [IQR 59.0-323.0] minutes; 20 (25 %) of patients received their antibiotics in the first hour from presentation. Independent predictors of PICU LOS were PRISM-III, and severe underlying co-morbidity, but not time to antibiotics. In the septic shock subgroup, the volume of fluid boluses given in the first 2 hours was independently associated with longer PICU LOS (effect size 0.22 days; 95 % CI 0.5, 0.38; per ml/kg). Independent predictors of ventilator days were PRISM-III score and severe underlying co-morbidity. In the septic shock subgroup, volume of fluid boluses in the first 2 hours was independently associated with more ventilator days (effect size 0.09 days; 95 % CI 0.02, 0.15; per ml/kg). CONCLUSION: Higher volume of early fluid boluses in children with sepsis and septic shock was independently associated with longer PICU LOS and ventilator days. More study on the benefits and harms of fluid bolus therapy in children are needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-1010-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4539944
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45399442015-08-19 Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care van Paridon, Bregje M. Sheppard, Cathy G, Garcia Guerra Joffe, Ari R. Crit Care Research INTRODUCTION: Early administration of antibiotics for sepsis, and of fluid boluses and vasoactive agents for septic shock, is recommended. Evidence for this in children is limited. METHODS: The Alberta Sepsis Network prospectively enrolled eligible children admitted to the Pediatric Intensive Care Unit (PICU) with sepsis from 04/2012-10/2014. Demographics, severity of illness, and outcomes variables were prospectively entered into the ASN database after deferred consent. Timing of interventions were determined by retrospective chart review using a study manual and case-report-form. We aimed to determine the association of intervention timing and outcome in children with sepsis. Univariate (t-test and Fisher’s Exact) and multiple linear regression statistics evaluated predictors of outcomes of PICU length of stay (LOS) and ventilation days. RESULTS: Seventy-nine children, age median 60 (IQR 22–133) months, 40 (51 %) female, 39 (49 %) with severe underlying co-morbidity, 44 (56 %) with septic shock, and median PRISM-III 10.5 [IQR 6.0-17.0] were enrolled. Most patients presented in an ED: 36 (46 %) at an outlying hospital ED, and 21 (27 %) at the Children’s Hospital ED. Most infections were pneumonia with/without empyema (42, 53 %), meningitis (11, 14 %), or bacteremia (10, 13 %). The time from presentation to acceptable antibiotic administration was a median of 115.0 [IQR 59.0-323.0] minutes; 20 (25 %) of patients received their antibiotics in the first hour from presentation. Independent predictors of PICU LOS were PRISM-III, and severe underlying co-morbidity, but not time to antibiotics. In the septic shock subgroup, the volume of fluid boluses given in the first 2 hours was independently associated with longer PICU LOS (effect size 0.22 days; 95 % CI 0.5, 0.38; per ml/kg). Independent predictors of ventilator days were PRISM-III score and severe underlying co-morbidity. In the septic shock subgroup, volume of fluid boluses in the first 2 hours was independently associated with more ventilator days (effect size 0.09 days; 95 % CI 0.02, 0.15; per ml/kg). CONCLUSION: Higher volume of early fluid boluses in children with sepsis and septic shock was independently associated with longer PICU LOS and ventilator days. More study on the benefits and harms of fluid bolus therapy in children are needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-1010-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-17 2015 /pmc/articles/PMC4539944/ /pubmed/26283545 http://dx.doi.org/10.1186/s13054-015-1010-x Text en © van Paridon et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
van Paridon, Bregje M.
Sheppard, Cathy
G, Garcia Guerra
Joffe, Ari R.
Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care
title Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care
title_full Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care
title_fullStr Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care
title_full_unstemmed Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care
title_short Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care
title_sort timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539944/
https://www.ncbi.nlm.nih.gov/pubmed/26283545
http://dx.doi.org/10.1186/s13054-015-1010-x
work_keys_str_mv AT vanparidonbregjem timingofantibioticsvolumeandvasoactiveinfusionsinchildrenwithsepsisadmittedtointensivecare
AT sheppardcathy timingofantibioticsvolumeandvasoactiveinfusionsinchildrenwithsepsisadmittedtointensivecare
AT ggarciaguerra timingofantibioticsvolumeandvasoactiveinfusionsinchildrenwithsepsisadmittedtointensivecare
AT joffearir timingofantibioticsvolumeandvasoactiveinfusionsinchildrenwithsepsisadmittedtointensivecare
AT timingofantibioticsvolumeandvasoactiveinfusionsinchildrenwithsepsisadmittedtointensivecare